USA’s Food and Drug Administration adds further credence to PMI’s new smokeless cigarette invention
By Duncan Mlanjira The United States Food and Drug Administration (FDA) has added further credence to Phillip Morris International (PMI’s) new smokeless cigarette invention, the ‘IQOS’, saying scientific studies that were conducted show that switching completely from conventional cigarettes to IQOS system significantly reduces the body’s exposure to harmful chemicals. During his keynote address of the Webinar conference on Wednesday organised by Food & Drug Law Institute (FDLI), FDA’s Center Director, Mitchell Zeller attested that the IQOS system heats…









